Comparison of Oncotype Dx (ODx) 21-gene recurrence score (RS) in African American (AA) and Caucasian (C) patients with hormone receptor-positive (HR+), HER2-negative (HER2-), lymph node-negative (LNN) breast cancer (BC).

K. B. Kabaker; J. Canar; R. D. Rao; M. A. Cobleigh

doi:10.1200/jco.2011.29.15_suppl.620

Comparison of Oncotype Dx (ODx) 21-gene recurrence score (RS) in African American (AA) and Caucasian (C) patients with hormone receptor-positive (HR+), HER2-negative (HER2-), lymph node-negative (LNN) breast cancer (BC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.620 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 620-620

Author(s):

K. B. Kabaker ◽

J. Canar ◽

R. D. Rao ◽

M. A. Cobleigh

Keyword(s):

Breast Cancer ◽

African American ◽

Lymph Node ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Hormone Receptor Positive

Download Full-text

Evaluation of Prognosis in Hormone Receptor–Positive/HER2-Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score

Clinical Breast Cancer ◽

10.1016/j.clbc.2017.12.006 ◽

2018 ◽

Vol 18 (5) ◽

pp. 347-352 ◽

Cited By ~ 2

Author(s):

Jane Meisel ◽

Chao Zhang ◽

Cameron Neely ◽

Pia Mendoza ◽

Shuo You ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Hormone Receptor Positive ◽

Node Negative Breast Cancer ◽

Oncotype Dx Recurrence Score

Download Full-text

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.094 ◽

2016 ◽

Vol 42 (9) ◽

pp. S103

Author(s):

A. Munir ◽

S. Udyashankar ◽

D. Thomas ◽

G. Dazeley ◽

A. Huws ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Node Negative ◽

Hormone Receptor Positive ◽

Oncotype Dx Recurrence Score

Download Full-text

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer

SpringerPlus ◽

10.1186/s40064-015-0840-y ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 8

Author(s):

Nikhil G Thaker ◽

Karen E Hoffman ◽

Michael C Stauder ◽

Simona F Shaitelman ◽

Eric A Strom ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Node Negative ◽

Hormone Receptor Positive ◽

Node Negative Breast Cancer

Download Full-text

Clinical significance of 21-gene recurrence score assay for hormone receptor–positive, lymph node-negative breast cancer in early stage

Experimental and Molecular Pathology ◽

10.1016/j.yexmp.2019.04.013 ◽

2019 ◽

Vol 108 ◽

pp. 150-155

Author(s):

Yang Yu-qing ◽

Wang Lei ◽

Huang Mei-ling ◽

Xiao Jing-jing ◽

Wei Mei-chen ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Clinical Significance ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Positive Lymph Node ◽

Node Negative ◽

Hormone Receptor Positive ◽

Node Negative Breast Cancer

Download Full-text

Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03)

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1243-y ◽

2010 ◽

Vol 127 (3) ◽

pp. 739-749 ◽

Cited By ~ 54

Author(s):

Masahide Kondo ◽

Shu-Ling Hoshi ◽

Takeharu Yamanaka ◽

Hiroshi Ishiguro ◽

Masakazu Toi

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Economic Evaluation ◽

Validation Study ◽

Hormone Receptor ◽

Early Stage ◽

Gene Signature ◽

Oncotype Dx ◽

Node Negative ◽

Hormone Receptor Positive

Download Full-text

Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor–Positive Lymph Node–Negative Early-Stage Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-16-0155 ◽

2016 ◽

Vol 22 (20) ◽

pp. 5043-5048 ◽

Cited By ~ 16

Author(s):

Ivana Sestak ◽

Yi Zhang ◽

Brock E. Schroeder ◽

Catherine A. Schnabel ◽

Mitch Dowsett ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Early Stage ◽

Recurrence Score ◽

Positive Lymph Node ◽

Early Stage Breast Cancer ◽

Node Negative ◽

Hormone Receptor Positive ◽

Breast Cancer Index

Download Full-text

Abstract PS5-37: The feasibility of obtaining oncotype DX breast recurrence score®results from metastatic sites of patients with hormone receptor positive metastatic breast cancer

10.1158/1538-7445.sabcs20-ps5-37 ◽

2021 ◽

Author(s):

Julie Anne L Gemmill ◽

Patricia Thompson ◽

Rebecca Batiste ◽

Caterina Vacchi-Suzzi ◽

Christina Preece ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Hormone Receptor ◽

Metastatic Breast ◽

Recurrence Score ◽

Oncotype Dx ◽

Hormone Receptor Positive ◽

Metastatic Sites ◽

Breast Recurrence

Download Full-text

Breast cancer-specific survival in >4,600 patients with lymph node-positive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene recurrence score® (RS) results in the SEER registries

Annals of Oncology ◽

10.1093/annonc/mdw364.07 ◽

2016 ◽

Vol 27 ◽

pp. vi45 ◽

Cited By ~ 2

Author(s):

D.P. Miller ◽

M. Roberts ◽

V.I. Petkov ◽

S. Shak ◽

N. Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Breast Cancer Specific Survival ◽

Cancer Specific Survival ◽

Node Positive ◽

Hormone Receptor Positive ◽

Lymph Node Positive

Download Full-text

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00667 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Mi Jeong Kwon ◽

Jeong Eon Lee ◽

Joon Jeong ◽

Sang Uk Woo ◽

Jinil Han ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Risk Classification ◽

Oncotype Dx ◽

Asian Women ◽

Hormone Receptor Positive ◽

Oncotype Dx Recurrence Score

Download Full-text

Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.12074 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 12074-12074

Author(s):

Catherine Margaret Kelly ◽

John Crown ◽

Niamh Russell ◽

Stephen Barron ◽

Seodhna Lynch ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Node Negative ◽

Prognostic Performance ◽

Hormone Receptor Positive ◽

Negative Lymph Node ◽

Node Negative Breast Cancer ◽

Multigene Signatures

Download Full-text